Cellebrite Increases 2024 Revenue Outlook From $370M - $380M To $390M - $398M (Est $378.306M); Sees $100M - $104M For Q3 (Est $94.77M)
Portfolio Pulse from Benzinga Newsdesk
Cellebrite has increased its 2024 revenue outlook from $370M-$380M to $390M-$398M, surpassing the estimated $378.306M. The company also projects Q3 revenue of $100M-$104M, exceeding the estimated $94.77M.
August 15, 2024 | 11:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cellebrite has raised its 2024 revenue outlook to $390M-$398M, surpassing the estimated $378.306M. The company also expects Q3 revenue of $100M-$104M, exceeding the estimated $94.77M.
The increase in revenue outlook for both 2024 and Q3 indicates strong business performance and growth prospects, likely leading to a positive short-term impact on CLBT's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100